Epigenomics AG / Key word(s): Corporate Action 06.11.2013 08:00 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, November 6, 2013 – Epigenomics AG (ISIN: DE000A1K0516, OTC: EPGNY) announces […]
Year: 2013
06. November 2013
Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics AG issues EUR 500,000 in convertible bonds to Yorkville
Read more
06. November 2013
Epigenomics AG: Epigenomics AG Announces 2013 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights
Epigenomics AG / Key word(s): Quarter Results 06.11.2013 / 08:30 Berlin, Germany, and U.S.A., November 6, 2013 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTC: EPGNY), the German-American cancer molecular diagnostics company, today announced its financial results for the third quarter and the nine months ending September 30, 2013. 9M 2013 revenue increased by 43% […]
31. October 2013
Epigenomics AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AG / Veröffentlichung der Gesamtzahl der Stimmrechte 31.10.2013 15:31 Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG, übermittelt durch die DGAP – ein Unternehmen der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. ————————————————————————— Hiermit teilt die Epigenomics AG mit, dass die Gesamtzahl der Stimmrechte am Ende des Monats […]
29. October 2013
Correction Notification: Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Correction of the announcement: Epigenomics AG increases share capital
Epigenomics AG / Key word(s): Capital Increase 29.10.2013 08:55 Dissemination of a Ad-hoc-correction according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Correction notifaction of the announcement of Epigenomics AG (Frankfurt Prime Standard: ECX; ISIN: DE000A1K0516) according […]
29. October 2013
Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Epigenomics AG successfully completes private placement of newly issued shares
Epigenomics AG / Key word(s): Capital Increase 29.10.2013 23:44 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Not for distribution in the United States Berlin, Germany, October 29, 2013 – […]
28. October 2013
Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act): Epigenomics AG increases share capital
Epigenomics AG / Key word(s): Corporate Action 28.10.2013 21:00 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Not for distribution in the United States Berlin, Germany, October 28, 2013 – […]